Mesenchymal stem cell transplantation is undergoing extensive evaluation as a cellular
therapy in human clinical trials. Because MSCs are easily isolated and amenable to culture …

Extracellular vesicles (EVs) carry diverse bioactive components including nucleic acids,
proteins, lipids and metabolites that play versatile roles in intercellular and interorgan …

Extracellular vesicles (EVs) are cell‐derived nanosized vesicles that mediate cell‐to‐cell
communication via transporting bioactive molecules and thus are critically involved in …

Cancer stands as a prominent contributor to global mortality rates, necessitating immediate
attention toward the exploration of its treatment options. Extracellular vesicles have been …

Mesenchymal stem cells (MSCs) are multipotent stromal cells that can be obtained from
various human tissues and organs. They can differentiate into a wide range of cell types …

Exosomes are the smallest subset of extracellular signaling vesicles secreted by most cells
with the ability to communicate with other tissues and cell types over long distances. Their …

Decades of research into the molecular mechanisms of cancer and the development of
novel therapeutics have yielded a number of remarkable successes. However, our ability to …

Bone marrow-derived mesenchymal stem cells (MSCs) have successfully progressed to
phase III clinical trials successive to an intensive in vitro and pre-clinical assessment in …

Mesenchymal stem cells (MSCs) represent a heterogeneous cellular population responsible
for the support, maintenance, and regulation of normal hematopoietic stem cells (HSCs). In …

Acute myeloid leukemia (AML) is a quickly aggressive hematopoietic disorder that progress
due to the accumulation and clonal expansion of immature myeloid cells. Despite the latest …